Company Filing History:
1 out of 37 
1 out of 1 
1 out of 98 
Years Active: 2013
Title: Misako Umehashi: Innovator in Antitussive Pharmaceutical Composition
Introduction
Misako Umehashi is a notable inventor based in Kumamoto, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antitussive agents. Her innovative work focuses on addressing chronic cough through a unique biochemical approach.
Latest Patents
Umehashi holds a patent for a plasma protein effective for suppressing cough. The patent describes the activated Factor XI as an antitussive for cough caused by stimulation at the tracheal bifurcation. This pharmaceutical composition aims for the prevention, treatment, and symptom amelioration of cough. It comprises a polypeptide chain as an active ingredient and a pharmaceutically acceptable carrier. The polypeptide chain consists of a full-length amino acid sequence constituting activated Factor XI, with possible modifications such as deletions, substitutions, or additions.
Career Highlights
Throughout her career, Umehashi has worked with esteemed institutions, including the Chemo-Sero-Therapeutic Research Institute and Ginkgo Academy Kumamoto Health Science University. Her research has significantly advanced the understanding of cough mechanisms and potential treatments.
Collaborations
Umehashi has collaborated with notable colleagues, including Shintaro Kamei and Asami Shindome. These partnerships have fostered a productive research environment, leading to innovative solutions in the pharmaceutical field.
Conclusion
Misako Umehashi's contributions to the development of antitussive agents highlight her role as a pioneering inventor in the pharmaceutical industry. Her work continues to influence the treatment of chronic cough, showcasing the importance of innovation in healthcare.